| 1310726-60-3 Basic information More.. |
Product Name: | Upadacitinib | Synonyms: | Upadacitinib;ABT-494(Upadacitinib) free base;ABT-494 (Upadacitinib);Upadacitinib (Rinvoq);ABT-494; ABT494; ABT 494;CS-2730;Upacidatinib;ABT-494 | CAS: | 1310726-60-3 | MF: | C17H19F3N6O | MW: | 380.37 | EINECS: | 213-161-9 | Mol File: | 1310726-60-3.mol | |
Use
Upadacitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). Upadacitinib may be used as monotherapy or in combination with methotrexate.
- Upadacitinib
-
- US $1.00-1.00 / kg
- 2024-10-06
- CAS:1310726-60-3
- Min. Order: 0.01kg
- Purity: 99
- Supply Ability: 50
- Upadacitinib
-
- US $0.00-0.00 / Kg/Bag
- 2024-10-04
- CAS:1310726-60-3
- Min. Order: 1Kg/Bag
- Purity: 0.99
- Supply Ability: 20 tons
- Upadacitinib
-
- US $57.00-52.00 / box
- 2024-09-30
- CAS:1310726-60-3
- Min. Order: 1box
- Purity: 99%
- Supply Ability: 5000 box
|
1310726-60-3
Recommend Suppliers |
|